Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

69662 pET-16b DNA - Novagen

Novagen's pET-16b vector carries an N-terminal His•Tag® sequence followed by a Factor Xa site and three cloning sites.

pET-16b DNA - Novagen MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
69662
Purchase on Sigma-Aldrich

概述

Replacement Information

Products

产品目录编号包装 数量 / 包装
69662-3CN 塑胶安瓿;塑胶针药瓶 10 μg
Description
OverviewThe pET-16b vector carries an N-terminal His•Tag® sequence followed by a Factor Xa site and three cloning sites. Note that the sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the vector map (TB046).

The pET Vectors are supplied as purified plasmid DNA (10 µg). Each order of pET DNA also includes an Induction Control strain (supplied as a glycerol stock). Please contact technical service if you need additional information.




This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@milliporesigma.com.
This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
Catalogue Number69662
Brand Family Novagen®
References
Product Information
Quality LevelMQ100
Applications
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped with Blue Ice or with Dry Ice
Toxicity Standard Handling
Storage ≤ -70°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
69662-3CN 04055977274509

Documentation

pET-16b DNA - Novagen 分析证书

标题批号
69662

引用

标题
  • Rossi, F., et al. 2008. Journal of Biological Chemistry 283, 3559.
  • Kröning, N., et al. 2007. Journal of Biological Chemistry 282, 14018.
  • Otte, M.M., et al. 2007. Journal of Bacteriology 189, 7310.
  • Plamondon, P., et al. 2007. Infection and Immunity 75, 2929.
  • Sinha, K.M., et al. 2007. Journal of Biological Chemistry 282, 15114.
  • Yu, Z., et al. 2007. Nucleic Acids Research 35, 2107.
  • Colasante, C., et al. 2006Eukaryotic Cell 5, 1194.
  • Roelofs, M.F., et al. 2006. Journal of Immunology 176, 7021.
  • Ashida, H., et al. 2005. Plant and Cell Physiology 46, 557.
  • Beernink, P.T, et al. 2005. Journal of Biological Chemistry 280, 30206.
  • Bruck, I., et al. 2005. Journal of Biological Chemistry 280, 18152.
  • Funa, N., et al. 2005. Journal of Biological Chemistry 280, 14514.
  • Hambsch, B., et al. 2005. Journal of Biological Chemistry 280, 15888.
  • Iwata, T., et al. 2005. Clinical Cancer Research 11, 3949.
  • Korepanova, A., et al. 2005. Protein Science 14, 148.
  • Liu, D., et al. 2005. Cancer Research 65, 3796.
  • O'Brien, P.J., et al. 2005. Clinical Chemistry 51, 351.
  • Annabelle Varrot, A., et al. 2005. Journal of Biological Chemistry 280, 20181.
  • Wilkinson, A., et al. 2005. Biochimica et Biophysica Acta 1749, 113.
  • Zhao, X., et al. 2005. Cancer Research 65, 2125.
  • Zhu H., and Shuman S. 2005. Journal of Biological Chemistry 280, 418.
  • Andrews, S.R., et al. 2004. Journal of Biological Chemistry 279, 54369.
  • Kobayashi, D., et al. 2003.Plant and Cell Physiology 44, 269.
  • Huhtinen, K., et al. 2002. Journal of Biological Chemistry 277, 3424.
  • Funa, N., et al. 1999. Nature 400, 897.
  • Zheng N. and Gierasch L.M. 1997. Molecular Cell 1, 79.
  • Deveraux, Q., et al. 1995. Journal of Biological Chemistry 270, 23726.
  • Ong, O.C., et al. 1995. Journal of Biological Chemistry 270, 8495.
  • Gotoh, Y., et al. 1994. Oncogene 9, 1891.
  • Franke, C.A. and Hruby, D.E.1993. Protein Expression and Purification 4, 101.
    		•

    用户协议

    标题
    TB053 Academic and Non-profit Laboratory Assurance Letter
    TB055 pET System Manual

    载体图

    标题
    TB046VM pET-16b Vector Map